Multiple Sclerosis: Improvement of Visuoperceptive Functions by Picotesla Range Magnetic Fields

References

• Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Beckwith B. E., Sandman C. A., Hothersall D., Kastin A. J. Influence of neonatal injections of alpha‐MSH on learning, memory and attention in rats. Physiology & Behavior 1977; 18: 63–71
   PubMed Web of Science ®Google Scholar
• Bentin S., Silverberg R., Gordon H. W. Asymmetrical cognitive deterioration in demented and parkinsonian patients. Cortex 1981; 17: 533–544
   PubMed Web of Science ®Google Scholar
• Botez M. I., Gravel J., Attig E., Vezina J. L. Reversible chronic cerebellar ataxia after phenytoin intoxication: Possible role of cerebellum in cognitive thought. Neurology 1985; 35: 1152–1157
   PubMed Web of Science ®Google Scholar
• Botez M. I., Botez T., Elie R., Atting E. Role of the cerebellum in complex human behavior. Italian Journal of Neurological Sciences 1989; 10: 291–300
   PubMedGoogle Scholar
• Brownell B., Hughes J. T. The distribution of plaques in the cerebrum in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1962; 25: 315–320
   PubMed Web of Science ®Google Scholar
• Bubenik G. A., Brown G. M., Grota J. L. Differential localization of N‐acetyled indolalkylamines in CNS and the Harderian gland using immunohistology. Brain Research 1976; 118: 417–127
   PubMed Web of Science ®Google Scholar
• Caine E. D., Bamford H. A., Schiffer R. B. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Cardinali D. P., Vacas M. I., Estevez‐Boyer E. Specific binding for melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Charcot J. M. Lectures on the diseases of the nervous system delivered at la salpetriere, G. Sigerson. The New Sydenham Society, London 1877; 194–195
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Daffner K. R., Ahern G. L., Weintraub S., Mesulam M. M. Dissociated neglect behavior following sequential strokes in the right hemisphere. Annals of Neurology 1990; 28: 97–101
   PubMed Web of Science ®Google Scholar
• Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience & Bio‐behavioral Reviews 1980; 4: 451–458
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. Magnetic fields abolish the nychthemeral rhythmicity of responses of Purkinje cells to the pineal hormone melatonin in the pigeon's cerebellum. Neuroscience Letters 1986; 72: 158–162
   PubMed Web of Science ®Google Scholar
• Diers W. C., Brown C. C. Psychometric patterns associated with multiple sclerosis. Archives of Neurology and Psychiatry 1950; 63: 760–765
   PubMedGoogle Scholar
• Dyster‐Aas K., Schally A. V., de Parra M. L. V., Velasco M. Psychophysiologic correlates of MSH activity in man. Physiology & Behavior 1971; 7: 893–896
   PubMed Web of Science ®Google Scholar
• Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• French J. D. The reticular formation. Handbook of physiology, J. Fields, H. W. Magoun, V. E. Hall. American Physiological Society, Washington 1960; 1281–1306
   Google Scholar
• Goldstein G., Shelly C. H. Neuropsychological diagnosis of multiple sclerosis in a neuro‐psychiatric setting. Journal of Nervous and Mental Disease 1974; 158: 280–290
   PubMed Web of Science ®Google Scholar
• Gowers W. R. A manual of diseases of the nervous system2nd Edition. Churchill, London 1893
   Google Scholar
• Grant I., McDonald W. I., Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1984; 47: 250–255
   PubMed Web of Science ®Google Scholar
• Healton E. B., Navarro C., Bressman S., Brust J. C. M. Subcortical neglect. Neurology 1982; 32: 776–778
   PubMed Web of Science ®Google Scholar
• Heaton R. K., Nelson L. M., Thompson D. S. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting Clinical Psychology 1985; 53: 103–110
   PubMed Web of Science ®Google Scholar
• Heilman K. M., Schwartz H., Watson R. T. Hypoarousal in patients with neglect syndrome and emotional indifference. Neurology 1978; 28: 229–232
   PubMed Web of Science ®Google Scholar
• Heilman K. M., Watson R. T., Valenstein E. Neglect and related disorders. Clinical neuropsychology, K. M. Heilman, E. Valenstein. Oxford University Press, Oxford 1985; 243–293
   Google Scholar
• Henderson V. W., Alexander M. P., Naeser M. A. Right thalamic injury, impaired visuospatial perception, and alexia. Neurology 1982; 32: 235–240
   PubMed Web of Science ®Google Scholar
• Holmes S. W., Sugden D. Effects of melatonin on sleep and neurochemistry in the rat. British Journal of Pharmacology 1982; 76: 95–101
   PubMed Web of Science ®Google Scholar
• Ivnik R. J. Neuropsychological test performance as a function of the duration of MS‐related symptomatology. Journal of Clinical Psychiatry 1978; 39: 304–312
   PubMed Web of Science ®Google Scholar
• Izumi K., Donaldson J., Minnich J., Barbeau A. Quabain‐induced seizures in rats: modification by melatonin and melanocyte‐stimulating hormone. Canadian Journal of Physiology & Pharmacology 1973; 51: 572–578
   PubMed Web of Science ®Google Scholar
• Jambor K. L. Cognitive functioning in multiple sclerosis. British Journal of Psychiatry 1969; 115: 765–775
   PubMed Web of Science ®Google Scholar
• Johansson B., Ross B. E. 5‐hydroxyindolcacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology 1977; 11: 37–45
   Web of Science ®Google Scholar
• Kahana E., Leibowitz U., Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179–1185
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Redding T. W., Schally A. V. MSH activity in rat pituitaries after pincalectomy. Proceedings of the Society of Experimental Biology and Medicine 1967; 124: 1275–1277
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Schally A. V., Viosca S., Miller M. D. MSH activity in plasma and pituitaries of rats after various treatments. Endocrinology 1969; 84: 20–27
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Miller L. H., Gonzalez‐Barcena D., Hawley W. D., Dyster‐Aas K., Schally A. V., deParra M. L. V., Velasco M. Psychophysiologic correlates of MSH activity in man. Physiology & Behavior 1971; 7: 893–896
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Viosca S., Nair R. M. G., Schally A. V., Miller M. C. Interactions between pineal, hypothalamus and pituitary involving melatonin. MSH release‐inhibiting factor and MSH. Endocrinology 1972; 91: 1323–1328
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Lieberman H. R., Waldhauser F., Garfield G., Lynch H. J., Wurtman R. J. Effects of melatonin on human mood and performance. Brain Research 1984; 323: 201–207
   PubMed Web of Science ®Google Scholar
• Marczynski T. J., Yamaguchi N., Ling G. M., Grodzinska L. Sleep induced by the administration of melatonin (5‐methoxy‐N‐acetyltryptamine) to the hypothalamus in unrestrained cats. Experientia 1964; 20: 435–437
   PubMedGoogle Scholar
• Mesulam M. M. A cortical network for directed attention and unilateral neglect. Annals of Neurology 1981; 10: 304–325
   Web of Science ®Google Scholar
• Milner B. Visual recognition and recall after right‐temporal lobe excision in man. Neuropsy‐chologia 1968; 6: 191–209
   Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology. Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Moore‐Ede M. C., Campbell S. S., Reiter R. J. Introduction. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 3–10
   Google Scholar
• Neary D., Snowden J. S., Bowen D. M. Neuropsychological syndromes in presenile dementia due to certebral atrophy. Journal of Neurology Neurosurgery and Psychiatry 1986; 49: 163–174
   PubMed Web of Science ®Google Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1973; 55: 219–220
   Web of Science ®Google Scholar
• O'Donohue T. L., Dorsa D. M. The opiomelanotrophinergic neuronal and endocrine systems. Peptides 1982; 3: 353–395
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Paterson A. T., Rickerby J., Simpson J., Vickers J. Possible interaction of melanocyte stimulating hormone (MSH) and the pineal in the control of territorial aggression in mice. Physiology & Behavior. 1980; 24: 843–848
   PubMed Web of Science ®Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 725–730
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A., McQuillen M. P., Khatri B. O., Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology 1984; 41: 625–631
   PubMed Web of Science ®Google Scholar
• Robbins T. W. Cortical noradrenaline, attention and arousal. Psychological Medicine 1984; 14: 13–21
   PubMed Web of Science ®Google Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz‐Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandman C. A., George J., Walker B. B., Nolan J. D., Kastin A. J. Neuropeptide MSH/ACTH 4–10 enhances attention in the mentally retarded. Pharmacology, Biochemistry, and Behavior 1976; 5(suppl 1)23–28
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha‐melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Derpapas K. The effects of picoTesla range magnetic fields on visuospatial functions in multiple sclerosis. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth‐strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth‐strength magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone regulation by melatonin and serotonin. Nature 1973; 244: 230–231
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Snider R. S., Maiti A. Cerebellar contributions to the Papez circuit. Journal of Neuroscience Research 1976; 2: 133–146
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stankov B., Fraschini F., Reiter R. J. Melatonin binding sites in the central nervous system. Brain Research Reviews 1991; 16: 245–256
   PubMedGoogle Scholar
• Staples D., Lincoln N. B. Intellectual impairment in multiple sclerosis. Rheumatology & Rehabilitation 1979; 18: 153–160
   PubMedGoogle Scholar
• Stoupel E., Keret R., Assa S., Kaufman H., Shimshoni M., Laron Z. Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity. Neuroendocrine Letters 1983; 5: 365–368
   Web of Science ®Google Scholar
• Vacas M. I., Cardinali D. P. Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatonin. Neuroscience Letters 1979; 15: 259–263
   PubMed Web of Science ®Google Scholar
• Veith J. L., Sandman C. A., George J. M., Stevens V. C. Effects of MSH/ACTH 4–10 on memory, attention and endogenous hormone levels in women. Physiology & Behavior 1978; 20: 43–50
   PubMed Web of Science ®Google Scholar
• Vitte P. A., Harthe C., Pevet P., Claustrat B. Brain autoradiographic study in the golden hamster after intracarotid injection of ‘14C’ melatonin. Neuroscience Letters 1990; 110: 1–5
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N‐acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar
• Williams L. M., Morgan P. J., Hatings M. H., Lawson W., Davidson G., Howell H. E. Melatonin receptors sites in the Syrian hamster brain and pituitary. Localization and characterization using (125I’ Iodomelatonin. Journal of Neuroendocrinology 1989; 1: 315–320
   PubMed Web of Science ®Google Scholar
• Zimmerman H. M., Netsky M. G. The pathology of multiple sclerosis. Research Publications of the Association for Research in Nervous and Mental Disease 1950; 28: 271–312
   PubMedGoogle Scholar